BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

Objective To compare the efficacy, adverse effects and acceptability of the three most
common misoprostol regimens used with mifepristone for medical abortion. Design …

BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

OBJECTIVE: Mifepristone and oral misoprostol are typically used for medical abortion in
women up to 49 days of gestation, with a 36-to 48-hour interval between the medications …

Objective The objective of this study was to determine if a repeat dose of misoprostol
following mifepristone or a single dose of misoprostol increases the efficacy of medical …

Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …

OBJECTIVE: To assess the potential advantages of combined mifepristone–misoprostol
versus misoprostol-only for early medical abortion. METHODS: A double-blind randomized …

Please cite this paper as: von Hertzen H, Huong N, Piaggio G, Bayalag M, Cabezas E, Fang
A, Gemzell‐Danielsson K, Hinh N, Mittal S, Ng E, Chaturachinda K, Pinter B, Puscasiu L …

Mifepristone was recently approved in the United States. Regimens with shorter intervals
may be more acceptable. The objective of this study was to determine whether the oral route …

Objective Abortion-related complications remain one of the leading causes of maternal
morbidity and mortality worldwide. Nearly half of all abortions are unsafe, and the vast …